Data-driven precision medicine will be accelerated through data (records, images, omics) mobilisation, to generate insights to support care, improve survival and inform research. Multiple myeloma and bladder cancer will serve as a template for other cancer types.
2 - Novel markers that allow early diagnosis and optimization of treatment strategy
Advanced analytical methods will be applied to new markers and/or algorithms to stratify patients with regards to their possible response to treatment.
3 - Better treatment options, delivered to patients faster
Healthcare professionals will be supported to deliver better targeted treatments more effectively and proactively to patients. The potential of care pathway automation will be explored.
4 - Novel disease insights and accelerated treatment development
New understandings in oncology care will be pioneered through integrating care and research, that can lead to improved outcomes for each patient.